These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9248117)

  • 1. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.
    Hatlebakk JG; Berstad A; Carling L; Svedberg LE; Unge P; Ekström P; Halvorsen L; Stallemo A; Hovdenak N; Trondstad R
    Scand J Gastroenterol; 1993 Mar; 28(3):224-8. PubMed ID: 8446846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL; Houcke P; Samoyeau R;
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
    Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
    Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE; Kahrilas PJ; Sontag SJ; Kovacs TO; Huang B; Pencyla JL
    Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
    Berstad A; Hatlebakk JG
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():34-6, discussion 61-6. PubMed ID: 8490077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P; Fuchs W; Peifer-Weiss A; Simon B
    Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G; Di Fede F
    Clin Ther; 1993; 15 Suppl B():2-13. PubMed ID: 7911400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effect of proton pump inhibitors on reflux esophagitis].
    Sekiguchi T; Horikoshi T; Nishioka T; Kusano M
    Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
    Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis.
    Newton M; Burnham WR; Kamm MA
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):753-8. PubMed ID: 9831269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.